Commissioning of 6 and 10 MV Beams for Total Body Irradiation (TBI)
DOI:
https://doi.org/10.15392/2319-0612.2023.2295Keywords:
TBI, Commissioning, TreatmentAbstract
The objective of the TBI treatment is the ablation of the bone marrow and the destruction of the circulating leukemia cells, once they are widely distributed throughout the body. Using beam parameters acquired under conventional SSD in TBI treatments may add non-negligible uncertainties in the monitor units calculation or in the beam profiles. The study, aims to commission the 6 and 10 MV photon beams, of the Varian accelerator CX model. A slab phantom and dosimetric assembly were used under TBI conditions. The accuracy of the TPS was evaluated against the experimental data. A set of data were acquired, highlighting the TPR table and methodology for calculating MU has been implemented. The TPS has presented a statistical uncertainty of ± 2.7 % compared to the experimental data for monitor unit calculation. The use of an acrylic spoiler has been shown to be clinically advantageous where, for a 6 MV beam, the entrance PDD was 75 % without a spoiler and 99.5 % with a spoiler. For a 10 MV beam, it was verified that without a spoiler, the entrance PDD was about 55 %, but with a spoiler, it was about 93 %. For medium Heterogeneous the TPS underestimated dose values by up to - 3.5 % with a mean deviation of – 2.9 %, for 6 MV and for 10 MV, the TPS overestimated the dose values by up to 1.1 %, with an average deviation of 1.0 % using the acrylic thorax phantom. The data obtained can be used clinically.
Downloads
References
KRISTUFEK, B. ; FRANK, T.et al ALL SCTped 2012 FORUM Allogeneic Stem Cell Transplantation in Children and Adolescents with Acute Lymphoblastic Leukaemia. International Therapy Protocol Version 5.0 /April 3, 2019.
STORB,R. ; RAFF,R. ; PEPE, M. et al. Comparison of Fractionated to Single-Dose Total Body Irradiation in Conditioning Canine Littermates for DLA-Identical Marrow Grafts. Agust 15, 1989.
BARON,F. ; MARIS,M.B. etal.Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning. Journal of clinical oncology, v. 23, number 9, March 20, 2005.
BUCHALI,A. ; FEYER,P. et al. Immediate Toxicity During Fractionated Total Dody Irradiation as Conditioning For Bone Marrow Transplantation. Radiotherapy and Oncology 54 (2000) 157-162
KHAN, F. The Physics of Radiation Therapy. Third edition, 2003.
Van Dyk, J. The modern technology of radiation oncology. V.1, 1999, Madison, Wisconsin, USA: Medical Physics Publishing.
HUSSAIN,A. ; BARAJAS,E.D. et al. Validation of the Eclipse AAA algorithm at extended SSD. Journal of applied clinical medical physics, v.11, number 3, summer 2010.
WILLS,C. ;CHERIAN.S et al. Total body irradiation : Pratical review.
VARIAN MEDICAL SYSTEMS, INC, Eclipse Photon and Electron Algorithms Reference Guide, march 2014.
VAN Dyk, J. ; PODGORSAK, E.B.et al. The physical aspects of total and half body photon irradiation, Task Group 29; p.13-25; New York ,1986.
KLEIN,E.E. ; HANLEY. J, et al. Quality Assurance of Medical Accelerator (TG-142). 2009 American Association of Physicists in Medicine.
LAMICHHANE, N. ; PATEL,V. et al, Going the distance: validation of Acuros and AAA at an extended SSD of 400 cm, Department of Radiation Oncology, University of Miami, Miami, FL, USA, Journal of applied clinical medical physics, v.17, number 2, 2016.
AKINO,Y. ; MARUOKA, S. ; YANO,K. et al; Commissioning of total body irradiation using plastic bead bags. Journal of Radiation Research, V.61, No. 6, 2020, pp. 959–968.
CANANOGLU, M. et al. Planning and dosimetric evaluation of three total body irradiation techniques: Standard SSD VMAT, Extended SSD VMAT and Extended SSD Field-in-Field, published 21 October 2022.
ZENG,Q. Evaluation of the Total Body Irradiation Treatment Planning Using Eclipse, Duke university, 2019.
Published
Issue
Section
License
Copyright (c) 2023 Brazilian Journal of Radiation Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing: The BJRS articles are licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
How to Cite
